*Neospora caninum* is an intracellular apicomplexan parasite that naturally infects dogs and cattle. The infectivity of *N. caninum* for humans is unknown. However, serological evidence suggests that humans are exposed to *N. caninum*[@b1]. Furthermore, *Neospora* DNA has been detected in experimentally infected rhesus macaques[@b2]. There are three infectious stages of *N. caninum*: tachyzoites, bradyzoites in tissue cysts, and sporozoites from oocysts. Dogs probably become infected via the ingestion of tissue containing bradyzoites and cattle via the ingestion of food or drink contaminated with oocysts. Although the proliferation of tachyzoites can occur in many organs, including the heart, lung, liver, and skin, neuromuscular disorder is the clinically most important in canine neosporosis[@b3]. In cattle, *N. caninum* is a major cause of abortion worldwide, and calves with congenital infections can show neurological signs[@b4][@b5]. Tissue cysts are predominantly formed in the central nervous systems (CNS), and *N. caninum* is thought to show tropism for the nervous system.

*Neospora caninum* can cause fatal diseases in dogs of all ages, although most cases of clinical neosporosis are reported in puppies, which often show characteristic pelvic limb paralysis and rigid hyperextension[@b3][@b6]. In contrast, a variety of neurological signs are observed in adult dogs, and neurological symptoms are thought to depend on the site that is parasitized within CNS[@b5]. The intracellular multiplication of the tachyzoites and the subsequent cell rupture trigger the development of lesions in *N. caninum*-infected tissues[@b7]. However, the number of parasites is not always associated with the severity of the histopathological lesions in the brain[@b8][@b9], and the mechanism of the neuronal pathogenesis of neosporosis is unclear.

*Toxoplasma gondii* is closely related to *N. caninum* and causes abortion and neuronal disorders in humans and animals. It has also been suggested that chronic infection with *T. gondii* can involve behavioral changes and psychiatric disorders in humans and animals[@b10]. In a previous study, we investigated the gene expression profiles and histopathological changes in the brains of mice infected with *T. gondii*, and our findings indicated that *T. gondii* stimulated the immune response including antigen presentation and diminished signal transduction included small-GTPase-mediated signal transduction and vesicle formation, which both regulate neurological functions in the brain[@b11]. Therefore, changes in gene expression caused by *N. caninum* infection potentially contribute to the neuronal pathogenesis in *N. caninum*-infected animals.

Some strains of mice including BALB/c are susceptible to *N. caninum* and exhibit encephalitis caused by the parasite infection[@b12]. Therefore mice have been used widely as an infection model of neosporosis to investigate immune responses and vaccine efficacy[@b13]. In this study, to understand the mechanism of neuronal pathogenesis during subacute infection with *N. caninum*, we investigated the histopathological changes, the distribution of the parasite, and the gene expression profiles (using a whole-transcriptome shotgun sequencing approach, RNA-Seq) in the brains of mice infected with *N. caninum*.

Results
=======

Mice infected with *N. caninum* showed characteristic clinical signs and histopathological changes in the brain
---------------------------------------------------------------------------------------------------------------

Pathological severity was evaluated in 17 mice, and 10 of the 17 mice showed clinical signs of neosporosis including febrile responses and leg paralysis 39 days after infection (See [Figure 1A](#f1){ref-type="fig"}). Seven of 10 symptomatic mice showed neurological signs, including circling motion, head tilting, and leg paralysis. We analyzed the nine area of brain histopathologically and for the quantification of parasite load. Histopathological lesions, including perivascular cuff, mononuclear cellular meningitis, glial cell activation, and focal necrosis, were observed in the brains of all 17 mice, which are similar to the lesions found in dogs[@b8][@b9][@b14][@b15]. Each focal lesion was scored for severity using a scale from 1 to 4 (See [Figure 2A--D](#f2){ref-type="fig"}). The total pathological scores for all areas in the brain are shown in [Figure 2E](#f2){ref-type="fig"}. The total scores for the frontal lobe and medulla oblongata were significantly higher in the symptomatic mice than in the asymptomatic mice. Although there were no significant differences between the symptomatic and asymptomatic mice in the cerebellum, two symptomatic mice showed very high scores.

Tachyzoites were found within some lesions, but no tissue cysts were found in the present study. Therefore, the tropism of tissue cysts was not determined histopathologically. We also investigated the distribution of the parasite in the brain with real-time PCR. The numbers of parasites for each area of the brain are shown in [Figure 2F](#f2){ref-type="fig"}. A sporadically high parasite load was detected in the frontal lobe and periaqueductal gray of the symptomatic mice. However we could not evaluate the difference of parasite number among the areas statistically because of small sample number. No association between the parasite load and the severity of the lesions was found. In an immunohistochemical analysis, the infiltration of macrophages or microglia and the production of inducible nitric oxide synthase (iNOS) were predominantly observed in the necrotic and inflammatory lesions (See [Figure 3](#f3){ref-type="fig"}).

Gene expression profiles are altered in their brains of mice infected with *N. caninum*
---------------------------------------------------------------------------------------

Eight mice, consisting of four *N. caninum*-infected mice and four uninfected mice, were used in the transcriptome analysis (See [Figure 1B](#f1){ref-type="fig"}). Two of the four *N. caninum*-infected mice showed clinical signs of neosporosis, including starry coat and hunched back, 39 days after infection. The numbers of parasites tended to be slightly higher in the symptomatic mice (See [supplementary Table S1](#s1){ref-type="supplementary-material"}). RNA obtained from the eight mice was subjected to high-throughput sequencing on an Illumina Genome Analyzer IIx. Eight libraries were sequenced and 34--47 million raw sequence reads were obtained per sample. Of these, 63.5%--84.9% could be mapped to the mouse genome (See [supplementary Table S2](#s1){ref-type="supplementary-material"}).

To identify the differentially expressed genes in the experimental groups, we analyzed the transcriptome data from the *N. caninum*-infected and uninfected mouse brains with DESeq. The magnitude distribution of the significantly altered genes was illustrated with an MA plot analysis (See [supplementary Figure S1](#s1){ref-type="supplementary-material"}). We analyzed 37,306 genes including 22,661 protein-coding genes. The expression of 772 protein-coding genes (2.1% of all analyzed genes and 3.4% of protein-coding genes) in the brains of the mice infected with *N. caninum* was significantly upregulated relative to their expression in the uninfected mice. The 30 most upregulated genes after infection with *N. caninum* are listed in [Table 1](#t1){ref-type="table"}. These 30 genes included genes for chemokines and chemokine receptors (*Cxcl9*, *Ccl8*, *Ccl5*, *Cxcl10*, and *Cxcr6*), immunoglobulins (*Ighg2c*, *Iglc2*, and *Igj*), interferon (IFN)-inducible GTPase family members (*Tgtp2*, *Gbp8*, and *Iigp1*), and MHC class II antigens (*Cd74*, *H2-Eb1*, *H2-Aa*, and *H2-Q7*). The quantitative PCR analysis showed that expression of *Ccl8*, *Ccl5*, *Cxcl10*, *Cxcr6*, *Tgtp2*, *Gbp8*, *Iigp1* and *Saa3* were significantly upregulated in the brains of *N. caninum*-infected mice (See [Figure 4](#f4){ref-type="fig"}). In contrast, only three genes (*Fcrls*, *Myoc*, and *Gkn3*) were significantly downregulated in the infected mice (See [supplementary Table S3](#s1){ref-type="supplementary-material"}). When the functional annotations of the genes upregulated by *N. caninum* infection were analyzed using GOstat, gene ontology (GO) terms associated with immune system processes, immune responses, and cell activation were represented significantly more strongly in the upregulated genes compared with the reference genes (See [Table 2](#t2){ref-type="table"}).

Gene expression levels correlate with the numbers of parasites in the brain
---------------------------------------------------------------------------

To investigate whether the fragments/kb of transcripts/million fragments mapped (FPKM) value correlates with the number of parasites in the infected mouse brain, the correlation coefficients were calculated. Seven hundred and twenty-two genes correlated positively with the numbers of parasites measured, whereas 320 genes showed negative correlations. There were 253 genes overlapping between genes upregulated by infection and genes correlated positively with the number of parasites (See [supplementary Table S4](#s1){ref-type="supplementary-material"}). Ten (*Cd8a*, *F10*, *F830016B08Rik*, *Il1rn*, *Lcn2*, *Cxcl10*, *Kirk1*, *Gimap7*, *Cxcr6* and *Irg1*) of the 30 genes most upregulated in *N. caninum* infected mice were not overlapped with the genes correlated positively with the number of parasites. [Table 3](#t3){ref-type="table"} and [Table 4](#t4){ref-type="table"} show the thirty most overrepresented GO terms for the genes that correlated positively and negatively with the parasites load, respectively. The GOstat analysis showed that the genes whose expression correlated positively with parasite numbers were associated with lysosome and ribosome in addition to immune responses. In contrast, the statistically overrepresented GO terms for the genes whose expression correlated negatively with parasite numbers involved cell and neuron projection, sterol and steroid metabolic processes, and synaptic transmission. These results indicate that *N. caninum* stimulates translational activation and intracellular digestion and reduce cell morphogenesis, including that of axons and dendrites, lipid metabolism, and neural transmission.

Gene expression profiles of symptomatic mice differed from those of asymptomatic animals
----------------------------------------------------------------------------------------

The severity of the clinical signs of neosporosis differed among the *N. caninum*-infected mice (See [supplementary Table S1](#s1){ref-type="supplementary-material"}). To identify differences in the gene expression profiles associated with the development of neosporosis, the genes expressed differentially between symptomatic and asymptomatic mice were analyzed with DESeq. The expression of no gene was higher in the symptomatic mice than in the asymptomatic mice, but the expression of eight genes was lower in the symptomatic mice than in the asymptomatic mice (See [Table 5](#t5){ref-type="table"}). These genes encoded solute carrier family 6 (a neurotransmitter transporter, serotonin), member 4 (SLC6A4), solute carrier family 6 (a neurotransmitter transporter, glycine), member 5 (SLC6A5), tryptophan hydroxylase 2 (TPH2), and low-density lipoprotein receptor (LDLR). Although we could not evaluate the difference of gene expression between symptomatic and asymptomatic mice statistically because of small sample number, *Slc6a4, slc6a5, Tph2 and ldlr* tended to be downredulated in symptomatic mice in quantitative PCR analysis (See [Figure 4](#f4){ref-type="fig"}).

Discussion
==========

The BALB/c mouse is known to be susceptible to the development of encephalitis induced by *N. caninum* and encephalitis is observed several weeks after inoculation[@b12][@b16]. In a previous study of *T. gondii*-infected mouse brains, we showed that the frontal lobe was more affected than any other area of the brain, whereas tissue damage and parasite infection were minor in the cerebellum[@b11]. The frontal lobe and medulla oblongata were mainly affected in symptomatic mice infected with *N. caninum* and some mice showed severe histopathological lesions in the cerebellum. Therefore, lesion formation in the medulla oblongata and the cerebellum may be characteristic of *N. caninum* infection. These results suggest that damage to neuronal tissues in the frontal lobe, medulla oblongata, and cerebellum is associated with the pathogenesis of neosporosis. Some infectious diseases including listeriosis show brain stem tropism[@b17]. *Listeria monocytogens*, which is enable to survive and multiply in macrophages, invades in the brain by centripetal migration along cranial nerve[@b17] and interaction between infected myeloid cell and endothelium[@b18]. *T. gondii* and *N. caninum* are thought to be delivered to organs by infected leukocytes in the blood. Although no association between the severity of the lesions and parasite numbers was found, endothelium in brain stem may be prone to adhere to pathogen-infected leukocyte and obstruction by leukocyte adhesion may lead to the damage of parenchyma of brain. Expression of adhesion molecule in each area of brain is intriguing. In some adult cases of canine neosporosis, the cerebellum and brainstem are predominantly affected[@b8][@b14][@b15]. Those cases suggest that the cerebellum can be the most commonly affected region in adult dogs with neosporosis[@b14]. Therefore, the murine model of neosporosis could be help clarifying the pathology in adult dogs.

In this study, no association between the parasite load and the severity of the lesions in each area was found. In canine neosporosis, a disassociation between parasite density and the severity of tissue damage has also been reported in adult cases[@b8][@b9]. Therefore, host factors, which can cause or exacerbate tissue damage, may be involved in the pathogenesis of neosporosis. In the brains of *N. caninum* infected mice, infiltration of macrophages or microglia and the production of iNOS were observed in the lesions. Activated microglia and astrocyte produce neurotoxic factors including nitric oxide (NO). NO produced by activated microglia and astrocytes inhibits neuronal respiration and causes glutamate release from neurons, which results in neuronal death from glutamate excitotoxicity via the N-methyl d-aspartate (NMDA) receptor[@b19][@b20]. Therefore, NO may be a factor that exacerbates brain tissue damage in neosporosis.

The 30 genes most strongly upregulated by *N. caninum* infection were similar to those upregulated in *T. gondii*-infected mice[@b11]. IFN-inducible GTPases play an important role in the host defense against intracellular pathogens, including *T. gondii*[@b21]. IIGP1 (IRGA6: immunity--related GTPase family member a6) is a member of the p47 GTPase family, and the accumulation of IIGP1 on the parasitophorous vacuole membrane of *T. gondii* resulted in the disruption of the membrane[@b22][@b23] and the necrotic death of the infected cell[@b23]. We showed that *Iigp1* was significantly upregulated in the brain of *T. gondii* infected mice in previous study[@b11]. ROP18 is a rhoptry kinase expressed highly by virulent *T. gondii* and phosphorylates and inactivates immunity-related GTPase (IRGs). However, genome sequencing and transcriptome analysis of *N. caninum* Liverpool strain revealed that *ROP18* in *N. caninu* is a pseudogene and *N. caninum* is unable to prevent the host from using IRGs to disrupt the parasitophorous vacuole[@b24]. This suggests that the growth of *N. caninum* could be inhibited effectively, which can lead to low parasite number in the lesions. A previous study showed that CXCL9/MIG, CXCL10/IP-10, and CCL5/RANTES are induced, dependent on IFN-γ, in the brains of BALB/c mice during chronic infection with *T. gondii*[@b25]. Protective immunity against *N. caninum* involves the Th1-type immune response, including IFN-γ and interleukin 12 (IL-12) production[@b16][@b26], and CCL5 induces the migration of Th1 cells via chemokine receptors including CCR5[@b27]. On the other hand, some studies have indicated that chemokines and their receptors are involved in exacerbating neuronal damage. Ischemic brain injury was exacerbated by a systemic increase in CCL5 during a Th1-polarized response induced by infection[@b28] and the downregulation of CCR5 protected the brain from neuron loss, inflammation, and seizure activity[@b29]. Therefore, the chemokines upregulated by *N. caninum* infection may be involved in both protective immunity and neuronal pathogenesis. *Saa3* expression was also highly upregulated in the mouse brain after *N. caninum* infection. Serum amyloid A (SAA) is an acute-phase protein, and a previous study suggested that SAA3 activates Toll-like receptor 2 (TLR2) and TLR4 as an endogenous ligand in astrocytes infected with herpes simplex virus type 1[@b30]. SAA3 is also produced in Schwann cells and macrophages in injured peripheral nerves[@b31]. Thus, SAA3 may act as a cytokine and be involved in the immune response and neuronal degeneration.

Only three genes (*Fcrls*, *Myoc*, and *Gkn3*) were significantly downregulated in the infected mice. *Myoc* is related to myelination in the peripheral nerve[@b32] and *Fcrls* was previously known as macrophage scavenger receptor 2 (*Msr2*) and is upregulated by mild traumatic brain injury[@b33], and downregulated in brain infected *T. gondii*[@b11] and Japanese encephalitis virus[@b34]. Although function of *Fcrls* is not well known in brain, downregulation of *Fcrls* is thought to be associated with host-pathogen interaction.

The GOstat analysis showed that the genes whose expression correlated negatively with parasite numbers involved cell and neuron projection, sterol and steroid metabolic processes, and synaptic transmission. Cholesterol is a component of cell membranes, and neurons and astrocytes demand high levels of cholesterol because they have the enormous membrane surfaces, encompassing their axons, dendrites, synapses, and processes[@b35]. Cholesterol is also required for cell regeneration after CNS injury and for the formation of new synapses. Cholesterol levels can also affect the biophysical function of membranes, and changes in cholesterol levels of membrane have been shown to affect the excitability of rat hippocampal neurons[@b36]. Therefore, changes in the expression of genes that are involved in cellular morphogenesis and lipid metabolism, including cholesterol, may be involved in the exacerbation of neuronal damage, impaired regeneration of damaged neuronal tissues, and the disruption of neurotransmission in mouse brains infected with *N. caninum*.

The expression of eight genes including *Hoxb5*, *Slc6a4, Slc6a5, Tph2* and *Ldlr* was lower in the symptomatic mice than in the asymptomatic mice. *Hoxb5* is a gene of gene family cording for transcription factors and Hoxb5 protein is expressed in mice lung during development[@b37]. A previous study demonstrated that mice deficient in glycine transporter 2 encoded by *Slc6a5* showed neuromotor abnormalities, such as spasticity, hind feet clasping, and tremor[@b38]. Tryptophan hydroxylase 2 encoded by *Tph2* is the key enzyme in brain serotonin synthesis[@b39], and it is possible that serotonergic neurons work poorly in mice that develop neosporosis. Therefore, the reduced expression of genes for neurotransmitter transporters may contribute to the development of neosporosis by modulating serotonergic and glycinergic neurotransmission.

In this study, we demonstrated that the frontal lobe and medulla oblongata were most often affected in *N. caninum*-infected mice with clinical signs and that there was no association between the parasite load and the severity of the histopathological lesions. Changes in the gene expression profile were also observed in the mouse brains after *N. caninum* infection. Genes associated with the immune response, encoding chemokines and IFN-inducible GTPase family members, were upregulated in the brains of mice infected with *N. caninum*. In contrast, the expression of genes associated with the morphogenesis of neurons, including their synapses and projections, with lipid metabolism, and with neuronal transmission correlated negatively with the number of parasites. These results suggest that neuronal tissue damage is caused by the inflammatory responses to parasite infection and can be exacerbated by the impairment of the regeneration of damaged neuronal tissue. Our results also suggest that neuronal transmission is affected by *N. caninum* infection at the level of gene transcription, and that neurological symptoms can be induced not only by organic damage but also by neuronal dysfunction.

Methods
=======

Ethics Statement
----------------

This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of Ministry of Education, Culture, Sports, Science and Technology, Japan. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Obihiro University of Agriculture and Veterinary Medicine (Permit number 25--59, 25--60, 25--62). All surgery was performed under isoflurane anesthesia, and all efforts were made to minimize animal suffering.

Mice
----

Mice used in this study were treated and used according to the Guiding Principles for the Care and Use of Research Animals published by the Obihiro University of Agriculture and Veterinary Medicine. Female BALB/c mice were obtained from CLEA Japan (Tokyo, Japan). The mice were housed under specific-pathogen-free conditions in the animal facility of the National Research Center for Protozoan Diseases at the Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan, before they were used in the experiments at 8 weeks of age.

Preparation of *N. caninum* tachyzoites and parasite infection of mice
----------------------------------------------------------------------

*Neospora caninum* tachyzoites of strain Nc-1[@b40] were propagated in monkey kidney adherent fibroblasts (Vero cells) cultured in Eagle\'s minimum essential medium (Sigma, St. Louis, MO, USA) supplemented with 8% heat-inactivated fetal bovine serum. For the purification of the tachyzoites, the parasites and host-cell debris were washed in cold phosphate-buffered saline (PBS), and the final pellet was resuspended in cold PBS and passed through a 27-gauge needle and a 5.0-μm pore filter (Millipore, Bedford, MA, USA). Eight-week-old mice were inoculated intraperitoneally with *N. caninum* parasites purified from an *in vitro* culture. All the mice were checked regularly for clinical signs of *N. caninum* infection, such as febrile responses (e.g., a starry stiff coat), hunched back, and limb paralysis.

Brain sampling
--------------

For the histopathological analysis, 25 mice were infected with 1 × 10^6^ *N. caninum*. Because six mice died or were euthanized before the scheduled date as a result of emaciation, 19 mice were sampled. Thirty-nine days after inoculation, at which time histopathological changes have occurred, the experimental mice were killed and their brains rapidly removed (See [Figure 1](#f1){ref-type="fig"}). The brains were fixed with a 10% neutral-buffered formalin solution for 6 days. We used these brains in the histopathological and immunohistochemical analyses. Two of 19 mice showed no clinical symptoms and no pathological changes. Because it was possible that the parasite had not infected these two mice, the distribution and severity of the brain lesions were estimated in the remaining 17 of 19 mice. Of the 17 mice, 10 mice showed clinical signs of neosporosis 39 days after infection (See [Figure 1](#f1){ref-type="fig"}).

Fourteen mice (four uninfected mice and 10 infected mice) were used for the detection of *N. caninum* and the RNA-Seq analysis (See [Figure 1](#f1){ref-type="fig"}). Thirty-nine days after infection, six infected mice showed the clinical signs of neosporosis and four animals did not. To detect *N. caninum* in different areas of the brain, six infected mice were selected (four symptomatic and two asymptomatic mice). The brains of these six infected mice were divided into eight different areas, the olfactory system, frontal lobe, caudate putamen, hippocampus, hypothalamus, amygdala, periaqueductal gray, and cerebellum. The samples to be used for DNA extraction and quantitative PCR of the parasites were stored at −20°C until analysis.

We used the other eight mice (four uninfected and four infected mice) to detect *N. caninum* in whole brain samples and in the RNA-Seq analysis. Of the four infected mice, two were symptomatic and two were asymptomatic. The brains of four infected mice and four uninfected mice were individually homogenized in 1 mL of TRI Reagent (Sigma-Aldrich, Tokyo, Japan). Each brain sample was then divided for DNA extraction (for quantitative PCR of the parasite numbers) or RNA extraction (for the RNA-Seq analysis).

Pathological analysis
---------------------

After fixation, the brain samples were cut coronally, embedded in paraffin wax, sectioned to 4 μm, and then stained with hematoxylin and eosin (HE). To estimate the severity of the histopathological lesions, they were scored with the following scheme: 0, no lesion; 1, minimal lesions limited to localized perivascular cuffs or slight mononuclear cell infiltration in the meninges; 2, mild lesions, including perivascular cuffs, meningitis, and local glial cell infiltration; 3, moderate lesions, including perivascular cuff, meningitis, glial cell activation, focal necrosis, and rarefaction of the neuropil, with occasional macrophage infiltration; 4, severe lesions, including perivascular cuffs, meningitis, glial cell activation, rarefaction of the neuropil, and extensive necrosis. The severity of the brain lesions was estimated in nine different areas including olfactory system, frontal lobe, caudate putamen, hippocampus, hypothalamus, amygdala, periaqueductal gray, medulla oblongata and cerebellum. The scores for each lesion were added for each area, and the total pathological score for each area was used in the data analysis. Pathological lesions representing the different scores are shown in [Figure 2A--D](#f2){ref-type="fig"}. Statistical significance of the differences between symptomatic and asymptomatic mice was investigated by t test. *P* \< 0.05 was considered statistically significant.

Immunohistochemical analysis of macrophages/microglia and iNOS
--------------------------------------------------------------

Immunohistochemistry was performed with antibodies directed against ionized calcium-binding adaptor molecule 1 (Iba1; Wako, Tokyo, Japan; diluted 1:2000) or inducible nitric oxide synthase (iNOS; Abcam, Cambridge, MA, USA; diluted 1:200) as the primary antibody and a secondary antibody conjugated with horseradish-peroxidase-labeled polymer (EnVision+ kit, DAKO, Copenhagen, Denmark). To immunostain for Iba1 and iNOS, deparaffinized sections were subjected to heat treatment in Tris--EDTA buffer (pH 9) and 10 mM citrate buffer (pH 6), respectively. Endogenous peroxidase activity was blocked by incubation with 3% H~2~O~2~ for 5 min at room temperature. The tissue sections were then incubated in goat serum for 30 min at room temperature to prevent nonspecific reactions. The sections were exposed to each primary antibody at 4°C overnight and then incubated with the secondary antibody for 40 min at 37°C. The signals were detected with diaminobenzidine (ImmPACT DAB®, Vector Laboratories Inc., Burlingame, CA, USA), followed by counterstaining with Mayer\'s hematoxylin.

DNA extraction and quantitative PCR for the detection of *N. caninum* DNA
-------------------------------------------------------------------------

To prepare DNA, the brain of each *N. caninum*-infected mouse was thawed in 10 times its volume of DNA extraction buffer (0.1 M Tris--HCl \[pH 9.0\], 1% SDS, 0.1 M NaCl, 1 mM EDTA) with 100 μg/mL proteinase K at 55°C. DNA was extracted with a commercial kit (DNeasy Blood & Tissue Kit; Qiagen, Hilden, Germany) with a standard protocol recommended by the manufacturer. In addition to eight areas of brain (olfactory system, frontal lobe, caudate putamen, hippocampus, hypothalamus, amygdala, periaqueductal gray, and cerebellum), we estimate the parasite load in medulla oblongata because relatively severe histopathological changes were observed in the area. To evaluate the parasite load in the medulla oblongata, we used the DNA extracted from paraffin-embedded tissue sections from the 17 mice used for the pathological analysis. The sections contained the medulla oblongata and cerebellum because we could not remove the cerebellum from the samples. DNA was extracted from the paraffin-embedded tissues with a commercial kit (QIAamp® DNA FFPE Tissue Kit; Qiagen). The parasite DNA was amplified as described previously[@b41]. Briefly, we used the SYBR Green PCR Core Kit (PE Applied Biosystems, Foster City, CA, USA) and primers complementary to the Nc5 gene of *N. caninum*: the forward primer spanning nucleotides 248--257 (5′-ACT GGA GGC ACG CTG AAC AC-3′) and the reverse primer spanning nucleotides 303--323 (5′-AAC AAT GCT TCG CAA GAG GAA-3′). Amplification, data acquisition, and data analysis were carried out in the ABI Prism 7900HT Sequence Detection System (Applied Biosystems), and the calculated cycle threshold values (Ct) were exported to Microsoft Excel for analysis as described previously[@b11]. The limit of detection was 0.1 parasites in 50 ng of tissue DNA.

Transcriptome sequencing
------------------------

Transcriptome sequencing was conducted as described previously[@b11]. Briefly, samples obtained from eight mice underwent poly-A selection with 1 μg of total RNA. Sequencing libraries were constructed with the RNA Sample Prep Kit (Illumina, San Diego, CA, USA); 36-bp single-end sequencing was performed using the Illumina Genome Analyzer IIx (Illumina) with the TruSeq SBS Kit v5-GA (36 cycle) (Illumina), according to the manufacturer\'s instructions. All treatment and following analyses associated with transcriptome sequencing were done individually.

Aligning sequence tags to the mouse genome and RefSeq
-----------------------------------------------------

Aligning sequence tags was conducted as described previously[@b11]. Briefly, the raw sequence reads were mapped to the mouse genome (mm10) using TopHat (ver. 1.3.3 doi:10.1093/bioinformatics/btp120) allowing two mismatches and gtf data (Mus_musculus.GRCm38.69). The normalized transcription profiles were estimated based on the mapping results using cufflinks (doi:10.1038/nbt.1621). The number of fragments/kb of transcript/million fragments mapped (FPKM) was converted from the raw read counts for each transcript. The MGI ID and gene ontology (GO) were obtained from the Mouse Genome Informatics database[@b42], and then integrated into the estimated expression profiles, together with the gene biotypes extracted from the gtf data.

Identification of differentially expressed genes
------------------------------------------------

Aligning sequence tags was conducted as described previously[@b11]. Briefly, differentially expressed genes were identified with the DESeq package in the R software[@b43], using a two-fold change (log2 fold-change \>1 or \<−1) and a 5% false discovery rate (FDR) cut-off for the thresholds. The expression intensity values were analyzed with an MA plot-based method after data normalization and the calculation of FDR.

Gene ontology (GO) analysis
---------------------------

The function of individual genes can be analyzed with GOstat (<http://gostat.wehi.edu.au/>), as described previously[@b11]. Using GOstat, we identified GO terms statistically overrepresented in the selected genes compared with the reference genes (all genes; 14938 genes). The statistical analysis was performed with a Benjamini correction, which controls FDR[@b44]. FDRs \< 0.05 were considered statistically significant.

Correlation between gene expression levels and parasite numbers
---------------------------------------------------------------

The correlation coefficients for the FPKM values and the numbers of parasites in the mouse brain were calculated using Pearson\'s correlation coefficient, as previously described[@b11]. The range of correlation coefficients for positive correlations was 0.7 to 1.0, and the no-correlation range was −0.7 to 0.7, whereas the range for negative correlation was −0.7 to −1. We analyzed genes that correlated positively or negatively with the number of parasites in the mouse brain using GOstat.

Quantitative reverse-transcription-PCR (qRT-PCR)
------------------------------------------------

Steady state mRNA expressions of the genes that upregulated by *N. caninum* infection and downregulated in symptomatic mice infected with the parasites were measured by qRT-PCR. Total RNA was extracted using TRI Reagent (Sigma, St Louis, MO, USA), from the left halves of brains. Reverse transcription was performed using Superscript III™ Reverse Transcriptase (Invitrogen, Life Technologies, Carlsbad, CA, USA), according to the manufacturer\'s instruction. Real-time PCR was performed using an Applied Biosystems Prism 7700 Sequence Detection System with SYBR Green master mix (AB Applied Biosystems, Life Technologies, Carlsbad, CA, USA). The fold change C~t~ method was used, where C~t~ is the threshold concentration (User Bulletin no. 2; Perkin-Elmer, Boston, MA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as a control. Specific primer sequences were shown in [Table S5](#s1){ref-type="supplementary-material"}.
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![Flow diagram illustrating the number of mice used in each analysis.\
(A) For the histopathological analysis, 25 mice were infected with *N. caninum*. Because eight of the 25 mice died before sampling or may not have been infected, the severity of the brain lesions in nine different areas (olfactory system, frontal lobe, caudate putamen, hippocampus, hypothalamus, amygdala, periaqueductal gray, medulla oblongata and cerebellum) was estimated in 17 mice (ten symptomatic and seven asymptomatic mice). (B) For the detection of *N. caninum* and the RNA-Seq analysis, 14 mice were used (four uninfected and 10 infected mice). Thirty-nine days after inoculation, six of the 10 infected mice showed clinical signs of neosporosis, but four animals did not. To detect *N. caninum* in different areas of the brain, six infected mice were selected (four symptomatic and two asymptomatic mice). The brains of these six infected mice were divided into eight different areas (olfactory system, frontal lobe, caudate putamen, hippocampus, hypothalamus, amygdala, periaqueductal gray, and cerebellum), and used for DNA extraction and quantitative PCR analysis of the parasite. Additionally, to detect *N. caninum* in the medulla oblongata, DNA was extracted from paraffin-embedded brain tissues containing the medulla oblongata and cerebellum (n = 17, from mice shown in [Figure 1A](#f1){ref-type="fig"}) and subjected to quantitative PCR. For the detection of *N. caninum* in whole-brain samples and the RNA-Seq analysis, four uninfected and four infected (two symptomatic and two asymptomatic mice) brains were used. DNA and RNA were extracted from each brain sample and used for the quantitative PCR analysis of the parasite numbers and the RNA-Seq analysis.](srep07936-f1){#f1}

![Histopathological lesions and parasite distributions in different areas of *N. caninum*-infected mouse brains.\
(A--D) Histopathological lesions in mouse brains infected with *N. caninum* (n = 17). To estimate the severity of the histopathological lesions, the lesions were scored as follows: (A) localized perivascular cuff (score 1), (B) local gliosis (score 2), (C) focal necrosis with moderate inflammatory cell infiltration (score 3), and (D) severe glial cell and macrophage infiltration, and rarefaction of the neuropil in extensive necrotic foci (score 4). (E) The total pathological scores for different mouse brain areas were determined as described in the Materials and Methods (ten symptomatic and seven asymptomatic mice). \*p \< 0.05 and \*\*p \< 0.01 (unpaired Student\'s *t*-test). (F) After DNA extraction from *N. caninum*-infected mouse brain samples (four symptomatic and two asymptomatic mice) and paraffin-embedded brain tissues, including the medulla oblongata and cerebellum (ten symptomatic and seven asymptomatic mice), parasite numbers were quantified by real-time PCR using primers specific for the *N. caninum* Nc5 gene.](srep07936-f2){#f2}

![Immunohistochemical analysis of macrophages/microglia and iNOS in lesions of *N. caninum*-infected mouse brain.\
(A--C) Serial sections of *N. caninum*-infected mouse brain. (A and A′) HE staining. (A′) A high-magnification image showing focal necrosis with mononuclear cell infiltration and cuffing. (B and B′) Immunohistochemical analysis with anti-Iba1 antibody. Infiltration of activated macrophages/microglia was observed around the necrotic area. (C and C′) Immunohistochemical analysis with an anti-iNOS antibody. Expression of iNOS was detected in inflammatory cells around the necrotic areas.](srep07936-f3){#f3}

![Gene expression analysis by quantitative PCR using RNA from the brain samples used in RNA-seq analysis.\
(A) Expression of the genes (*Saa3*, *Cxcl9*, *Ccl8*, *Ccl5*, *Cxcl10*, *Cxcr6, Tgtp2*, *Gbp8* and *Ligp1*) that upregulated by *N. caminum* infection. (B) Expression of the genes (*Slc6a4*, *Slc6a5*, *Tph2* and *Ldlr*) that downregulated in symptomatic mice infected with *N. caninum*. \**p* \< 0.05 and \*\**p* \< 0.01.](srep07936-f4){#f4}

###### Thirty genes most significantly upregulated in *N. caninum*-infected mouse brains

  Gene symbol                                                   Description                                                Average of FPMK   Fold change     FDR    
  --------------- ------------------------------------------------------------------------------------------------------- ----------------- ------------- --------- ----------
  Saa3                                                       serum amyloid A 3                                                  0.12           258.01      1989.26   3.33E-05
  Cxcl9                                              chemokine (C-X-C motif) ligand 9                                           0.01            19.27      1581.14   1.83E-07
  Ighg2c                                          immunoglobulin heavy constant gamma 2C                                        0.34           401.45      1196.80   1.53E-12
  Ccl8                                                chemokine (C--C motif) ligand 8                                           0.08            88.64      1065.20   3.29E-04
  Cd8a                                                   CD8 antigen, alpha chain                                               0.00            3.03       1029.22   6.60E-08
  F10                                                      coagulation factor X                                                 0.01            5.48       952.87    4.34E-06
  F830016B08Rik                                         RIKEN cDNA F830016B08 gene                                              0.00            2.52       917.74    1.30E-11
  Iglc2                                              immunoglobulin lambda constant 2                                           0.02            14.02      694.68    3.94E-07
  Ccl5                                                chemokine (C--C motif) ligand 5                                           0.38           231.64      611.07    3.11E-05
  Il1rn                                              interleukin 1 receptor antagonist                                          0.02            2.55       535.78    1.83E-06
  Tgtp2                                                  T cell specific GTPase 2                                               0.10            13.67      533.21    1.08E-11
  Lcn2                                                          lipocalin 2                                                     0.09            41.88      512.67    1.22E-09
  Nkg7                                             natural killer cell group 7 sequence                                         0.01            6.24       494.87    3.94E-07
  Cd74             CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)        2.57           1281.31     484.61    6.26E-10
  Gm4951                                                    predicted gene 4951                                                 0.81           355.49      484.61    7.30E-10
  H2-Eb1                                       histocompatibility 2, class II antigen E beta                                    0.77           217.08      461.83    5.20E-09
  Igj                                                  immunoglobulin joining chain                                             0.03            11.31      450.15    7.14E-06
  Gbp8                                                  guanylate-binding protein 8                                             0.05            20.43      389.61    2.04E-05
  Cst7                                                  cystatin F (leukocystatin)                                              0.17            43.87      387.41    1.78E-04
  Cxcl10                                             chemokine (C-X-C motif) ligand 10                                          1.60           530.34      378.75    1.51E-06
  H2-Aa                                       histocompatibility 2, class II antigen A, alpha                                   0.17            57.55      351.69    2.33E-10
  Iigp1                                                interferon inducible GTPase 1                                            0.06            29.46      339.64    1.25E-08
  Zbp1                                                    Z-DNA binding protein 1                                               0.01            1.94       334.68    2.61E-09
  Klrk1                                   killer cell lectin-like receptor subfamily K, member 1                                0.05            15.91      329.33    9.59E-05
  H2-Q7                                           histocompatibility 2, Q region locus 7                                        0.01            2.32       324.26    5.60E-12
  Gimap7                                               GTPase, IMAP family member 7                                             0.02            6.33       305.31    2.17E-04
  Apoc2                                                     apolipoprotein C-II                                                 0.01            2.63       303.69    1.64E-07
  Cxcr6                                             chemokine (C-X-C motif) receptor 6                                          0.10            22.60      295.81    1.30E-05
  Fcgr4                                              Fc receptor, IgG, low affinity IV                                          0.01            3.15       265.63    1.11E-04
  Irg1                                                    immunoresponsive gene 1                                               0.81           355.49      241.83    1.57E-05

(\>two-fold change and FDR \< 0.05)

###### GO terms for the most significantly upregulated genes in mouse brains after infection with *N. caninum*

  Accession                             GO term                           Reference genes   Up-regulated genes   FDR         
  ------------ --------------------------------------------------------- ----------------- -------------------- ----- ------ ----------
  GO:0002376                     immune system process                          566                3.8           184   28.4      0
  GO:0006952                       defense response                             353                2.4           104   16.0      0
  GO:0006955                        immune response                             346                2.3           138   21.3      0
  GO:0006954                     inflammatory response                          178                1.2           64    9.9    5.92E-64
  GO:0009897               external side of plasma membrane                     121                0.8           51    7.9    6.28E-59
  GO:0009986                         cell surface                               168                1.1           58    8.9    2.06E-55
  GO:0045321                     leukocyte activation                           189                1.3           60    9.2    1.41E-52
  GO:0001775                        cell activation                             202                1.4           62    9.6    1.64E-52
  GO:0009611                     response to wounding                           252                1.7           69    10.6   1.10E-51
  GO:0002682              regulation of immune system process                   92                 0.6           41    6.3    1.50E-49
  GO:0050776                 regulation of immune response                      90                 0.6           40    6.2    3.46E-48
  GO:0051239        regulation of multicellular organismal process              250                1.7           65    10.0   1.01E-45
  GO:0009605                 response to external stimulus                      393                2.6           83    12.8   1.57E-45
  GO:0046649                     lymphocyte activation                          173                1.2           53    8.2    1.36E-44
  GO:0042110                       T cell activation                            112                0.7           39    6.0    5.58E-37
  GO:0002252                    immune effector process                         113                0.8           38    5.9    1.10E-34
  GO:0051240    positive regulation of multicellular organismal process         96                 0.6           34    5.2    1.51E-32
  GO:0001816                      cytokine production                           95                 0.6           33    5.1    6.63E-31
  GO:0002520                   immune system development                        228                1.5           49    7.6    1.39E-26
  GO:0006935                          chemotaxis                                92                 0.6           30    4.6    4.22E-26
  GO:0042330                             taxis                                  92                 0.6           30    4.6    4.22E-26
  GO:0048534           hemopoietic or lymphoid organ development                212                1.4           45    6.9    6.89E-24
  GO:0019882              antigen processing and presentation                   43                 0.3           33    5.1    2.91E-23
  GO:0006950                      response to stress                            666                4.5           87    13.4   2.07E-22
  GO:0030097                          hemopoiesis                               190                1.3           40    6.2    8.01E-21
  GO:0005886                        plasma membrane                            1476                9.9           143   22.0   1.76E-20
  GO:0051249              regulation of lymphocyte activation                   76                 0.5           36    5.5    3.31E-20
  GO:0050865                 regulation of cell activation                      79                 0.5           36    5.5    8.86E-20
  GO:0048002    antigen processing and presentation of peptide antigen          28                 0.2           26    4.0    1.33E-19
  GO:0002521                   leukocyte differentiation                        118                0.8           30    4.6    1.33E-19

###### Thirty most overrepresented GO terms for the genes that correlated positively with the parasites load

  Accession                                              GO term                                            Reference gene   Genes positively correlated with parasite number   FDR         
  ------------ ------------------------------------------------------------------------------------------- ---------------- -------------------------------------------------- ----- ------ ----------
  GO:0002376                                      immune system process                                          566                               3.8                          93    15.0   1.29E-37
  GO:0006955                                         immune response                                             346                               2.3                          65    10.5   3.06E-31
  GO:0000323                                          lytic vacuole                                              153                               1.0                          40    6.5    8.65E-29
  GO:0005764                                            lysosome                                                 153                               1.0                          40    6.5    8.65E-29
  GO:0005773                                             vacuole                                                 173                               1.2                          41    6.6    3.18E-26
  GO:0019882                               antigen processing and presentation                                    43                               0.3                          28    4.5    4.23E-18
  GO:0048002                     antigen processing and presentation of peptide antigen                           28                               0.2                          23    3.7    3.31E-16
  GO:0006952                                        defense response                                             353                               2.4                          51    8.2    6.81E-16
  GO:0044444                                        cytoplasmic part                                             2791                              18.7                         196   31.7   1.28E-12
  GO:0005737                                            cytoplasm                                                4861                              32.5                         295   47.7   5.58E-12
  GO:0019884                    antigen processing and presentation of exogenous antigen                          22                               0.1                          16    2.6    2.34E-10
  GO:0002478                antigen processing and presentation of exogenous peptide antigen                      17                               0.1                          14    2.3    1.89E-09
  GO:0042611                                       MHC protein complex                                            19                               0.1                          14    2.3    4.69E-09
  GO:0006412                                           translation                                               385                               2.6                          44    7.1    1.60E-08
  GO:0002474             antigen processing and presentation of peptide antigen via MHC class I                   14                               0.1                          12    1.9    3.47E-08
  GO:0019886        antigen processing and presentation of exogenous peptide antigen via MHC class II             15                               0.1                          12    1.9    4.97E-08
  GO:0002495             antigen processing and presentation of peptide antigen via MHC class II                  15                               0.1                          12    1.9    4.97E-08
  GO:0003735                               structural constituent of ribosome                                    143                               1.0                          23    3.7    7.41E-08
  GO:0002504    antigen processing and presentation of peptide or polysaccharide antigen via MHC class II         16                               0.1                          12    1.9    7.57E-08
  GO:0002252                                     immune effector process                                         113                               0.8                          20    3.2    7.57E-08
  GO:0006954                                      inflammatory response                                          178                               1.2                          26    4.2    1.05E-07
  GO:0005840                                            ribosome                                                 148                               1.0                          23    3.7    1.83E-07
  GO:0030529                                    ribonucleoprotein complex                                        350                               2.3                          39    6.3    3.78E-07
  GO:0009897                                external side of plasma membrane                                     121                               0.8                          20    3.2    4.47E-07
  GO:0016064                             immunoglobulin mediated immune response                                  55                               0.4                          17    2.7    5.25E-07
  GO:0019724                                    B cell mediated immunity                                          56                               0.4                          17    2.7    6.41E-07
  GO:0005829                                             cytosol                                                 316                               2.1                          36    5.8    6.81E-07
  GO:0009611                                      response to wounding                                           252                               1.7                          31    5.0    7.65E-07
  GO:0002449                                  lymphocyte mediated immunity                                        75                               0.5                          19    3.1    8.81E-07
  GO:0002443                                   leukocyte mediated immunity                                        81                               0.5                          19    3.1    2.52E-06

(FDR \< 0.05)

###### Thirty most overrepresented GO terms for the genes that correlated negatively with the parasites load

  Accession                        GO term                      Reference gene   Genes negatively correlated with parasite number   FDR         
  ------------ ----------------------------------------------- ---------------- -------------------------------------------------- ----- ------ ----------
  GO:0042995                   cell projection                       333                               2.2                          23    8.9    6.75E-08
  GO:0043005                  neuron projection                      108                               0.7                          16    6.2    1.27E-06
  GO:0005886                   plasma membrane                       1476                              9.9                          56    21.7   2.07E-06
  GO:0051179                    localization                         2430                              16.3                         78    30.2   7.01E-06
  GO:0016192             vesicle-mediated transport                  375                               2.5                          21    8.1    9.05E-05
  GO:0006810                      transport                          2099                              14.1                         65    25.2   6.52E-04
  GO:0016125              sterol metabolic process                    67                               0.4                          10    3.9    6.52E-04
  GO:0051234            establishment of localization                2152                              14.4                         66    25.6   6.52E-04
  GO:0008202              steroid metabolic process                  130                               0.9                          13    5.0    6.52E-04
  GO:0048667     neuron morphogenesis during differentiation         153                               1.0                          14    5.4    6.52E-04
  GO:0048812                neurite morphogenesis                    153                               1.0                          14    5.4    6.52E-04
  GO:0016126             sterol biosynthetic process                  26                               0.2                           7    2.7    6.52E-04
  GO:0050808         synapse organization and biogenesis              39                               0.3                           8    3.1    6.52E-04
  GO:0007268                synaptic transmission                    179                               1.2                          15    5.8    6.52E-04
  GO:0000267                    cell fraction                        422                               2.8                          21    8.1    6.80E-04
  GO:0019226            transmission of nerve impulse                211                               1.4                          16    6.2    8.53E-04
  GO:0030424                        axon                              58                               0.4                           9    3.5    8.72E-04
  GO:0016020                      membrane                           6123                              41.0                         144   55.8   9.91E-04
  GO:0008324      cation transmembrane transporter activity          435                               2.9                          21    8.1    1.08E-03
  GO:0008203            cholesterol metabolic process                 61                               0.4                           9    3.5    1.08E-03
  GO:0007409                    axonogenesis                         146                               1.0                          13    5.0    1.10E-03
  GO:0006836             neurotransmitter transport                   46                               0.3                           8    3.1    1.10E-03
  GO:0000904    cellular morphogenesis during differentiation        172                               1.2                          14    5.4    1.10E-03
  GO:0030030     cell projection organization and biogenesis         252                               1.7                          17    6.6    1.10E-03
  GO:0048858           cell projection morphogeneisis                252                               1.7                          17    6.6    1.10E-03
  GO:0032990               cell part morphogenesis                   252                               1.7                          17    6.6    1.10E-03
  GO:0006695          cholesterol biosynthetic process                20                               0.1                           6    2.3    1.16E-03
  GO:0031175                 neurite development                     183                               1.2                          14    5.4    1.99E-03
  GO:0048699                generation of neuron                     299                               2.0                          16    6.2    2.12E-03
  GO:0015075       ion transmembrane transporter activity            595                               4.0                          25    9.7    2.46E-03

(FDR \< 0.05)

###### Genes significantly altered in brain samples from mice exhibiting clinical signs of neosporosis

  Gene symbol                                    Description                                   Average of FPMK   FPKM Fold change   FDR   
  ------------- ----------------------------------------------------------------------------- ----------------- ------------------ ------ -----------
  Hoxb5                                          homeobox B5                                        1.09               0.09         0.08   7.33.E-04
  Slc6a4         solute carrier family 6 (neurotransmitter transporter, serotonin), member 4        2.94               0.38         0.13   3.04.E-09
  BC037034                                 cDNA sequence BC037034                                   10.04              1.44         0.14   9.05.E-03
  Tph2                                    tryptophan hydroxylase 2                                  4.03               0.88         0.22   6.85.E-06
  Slc6a5          solute carrier family 6 (neurotransmitter transporter, glycine), member 5         4.15               0.95         0.23   3.84.E-06
  Mab21l2                                mab-21-like 2 (C. elegans)                                 3.26               1.08         0.33   2.41.E-02
  Fos                                     FBJ osteosarcoma oncogene                                 33.97             12.06         0.36   5.30.E-03
  Ldlr                                low density lipoprotein receptor                              7.42               2.89         0.39   9.05.E-03

(\>two-fold change and FDR \< 0.05)

[^1]: Current address: Sachi Tanaka, Frontier Agriscience and Technology Center, Faculty of Agriculture, Shinshu University.
